TrialPDA001 for the Treatment of Adults With Moderate-to-Severe Crohn's Disease
Trial details
- Registry ID
- NCT01155362
- Phase
- Phase 2
Drug research
Human Placenta-Derived Cells PDA001 Intravenous Infusion
Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.
Drug identity checked against registry records
A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.
Included trials
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| PDA001 for the Treatment of Adults With Moderate-to-Severe Crohn's DiseaseNCT01155362 | Celularity Incorporated | Phase 2 | Completed | 2012-02Actual |
Regulatory dates and decisions
| No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed. |